19 results
6-K
EX-99.2
GLPG
Galapagos NV
8 Aug 22
First key steps in pipeline rebuild and strong commercial progress in H1 2022
4:59pm
of filgotinibfor in the the supply manufacturing filgotinibof except filgotinib. for secondary The same manufacturing packaging and sites labelling thatfor
6-K
EX-99.2
GLPG
Galapagos NV
6 May 22
Current report (foreign)
5:18pm
manufacturing sites that supplied Gilead continue to supply filgotinib except for secondary packaging and labelling for which a new vendor has been
6-K
EX-99.2
GLPG
Galapagos NV
8 Nov 21
Galapagos reports commercial and operational progress at Q3 financial results
4:03pm
packaging and labelling for which a new vendor has been selected. Commercial organization The form of outreach of our commercial teams to physicians
6-K
EX-99.2
0lanui zg
5 Aug 21
Galapagos reports H1 financial results with refocused pipeline and operational progress
4:02pm
6-K
EX-99.3
jtti8xe
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.2
vyz3 dnxz3xuvel6qn
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
6-K
EX-99.3
ne5rxtdiyz
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
6-K
EX-1.1
uaxammpczyh68rb7
18 Apr 17
Galapagos announces launch of proposed public offering
12:00am
20-F
ojqhqxn
25 Mar 16
Annual report (foreign)
12:00am
DRS/A
EX-10
7tekg5wfm2 2n1wmx7v
4 Mar 15
Draft registration statement (amended)
12:00am
DRS/A
EX-10
2hxjtbq
4 Mar 15
Draft registration statement (amended)
12:00am
DRS
q43arv
6 Feb 15
Draft registration statement
12:00am
- Prev
- 1
- Next